The latest closing stock price for Rein Therapeutics as of June 04, 2025 is 2.00.
An investor who bought $1,000 worth of Rein Therapeutics stock at the IPO in 2017 would have $-991 today, roughly -1 times their original investment - a -44.30% compound annual growth rate over 8 years.
The all-time high Rein Therapeutics stock closing price was 298.20 on October 04, 2017.
The Rein Therapeutics 52-week high stock price is 4.40, which is 120% above the current share price.
The Rein Therapeutics 52-week low stock price is 1.35, which is 32.5% below the current share price.
The average Rein Therapeutics stock price for the last 52 weeks is 2.50.
An investor who bought $1,000 worth of Rein Therapeutics stock at the IPO in 2017 would have $-991 today, roughly -1 times their original investment - a -44.30% compound annual growth rate over 8 years.
The all-time high Rein Therapeutics stock closing price was 298.20 on October 04, 2017.
The Rein Therapeutics 52-week high stock price is 4.40, which is 120% above the current share price.
The Rein Therapeutics 52-week low stock price is 1.35, which is 32.5% below the current share price.
The average Rein Therapeutics stock price for the last 52 weeks is 2.50.